PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsOcriplasmin
Jetrea(ocriplasmin)
Jetrea (ocriplasmin) is a protein pharmaceutical. Ocriplasmin was first approved as Jetrea on 2012-10-17. It is used to treat retinal diseases in the USA. It has been approved in Europe to treat retinal diseases.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
eye diseasesD005128
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Ocriplasmin
Tradename
Proper name
Company
Number
Date
Products
JetreaocriplasminOxurionN-125422 DISCN2012-10-17
2 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
retinal diseasesD012164H35.9
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
S: Sensory organ drugs
S01: Ophthalmologicals
S01X: Other ophthalmologicals in atc
S01XA: Other ophthalmologicals in atc
S01XA22: Ocriplasmin
HCPCS
Code
Description
J7316
Injection, ocriplasmin, 0.125 mg
Clinical
Clinical Trials
523 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
StrokeD020521EFO_0000712I63.91644481350159
Ischemic strokeD0000832421247531833149
IschemiaD007511EFO_00005567141151448
ThrombosisD01392734116831
Myocardial infarctionD009203EFO_0000612I213157630
Pulmonary embolismD011655EFO_0003827I264910629
Cerebral infarctionD002544I6331173626
InfarctionD007238EFO_0009463386723
HemorrhageD006470MP_0001914R5821351122
EmbolismD0046171124412
Show 49 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Macular edemaD0082692214
Brain infarctionD020520EFO_0004277I63314
Vitreous detachmentD020255EFO_1001238H43.81123
Respiratory insufficiencyD012131J96.933
VitrectomyD01482133
Head and neck neoplasmsD006258123
Healthy volunteers/patients112
Hypertensive intracranial hemorrhageD020299112
Communicable diseasesD003141112
Intracranial vasospasmD020301EFO_1000994G45.91112
Show 24 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471C61213
Retinal vein occlusionD012170EFO_1001157H34.8133
Urinary bladder neoplasmsD001749C67213
Malignant pleural effusionD016066J91.011
ThrombophlebitisD01392411
Adjuvant chemotherapyD01702411
GallstonesD042882EFO_000421011
CholelithiasisD002769EFO_0004799K8011
CholecystolithiasisD041761EFO_100086411
Vision disordersD014786H53.1111
Show 5 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SepsisD018805EFO_0001420A41.977
ToxemiaD01411577
PeriodontitisD010518EFO_0000649K05.366
FibrinolysisD00534233
Chronic periodontitisD055113EFO_0006343K05.333
Acute kidney injuryD058186N1733
RuptureD01242122
Coagulation protein disordersD02014722
MortalityD009026EFO_000435222
Thrombotic strokeD00008324422
Show 83 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOcriplasmin
INNocriplasmin
Description
Ocriplasmin, sold under the brand name Jetrea, is a recombinant protease with activity against fibronectin and laminin, components of the vitreoretinal interface. It is used for treatment of symptomatic vitreomacular adhesion, for which it received FDA approval on 17 October 2012. It works by dissolving the proteins that link the vitreous to the macula, resulting in posterior detachment of the vitreous from the retina.
Classification
Enzyme
Drug classplasmin proteins and derivatives
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL2095222
ChEBI ID
PubChem CID
DrugBankDB08888
UNII ID7V6HE3DM5A (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 680 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
691 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use